Cholesterol & Lipid
Sort by:
Michigan Medicine
Statin Hepatotoxicity: Recognition and Management
FEATURING
Robert Fontana
- 867 views
- January 12, 2024
- 4
Canadian Collaborative Research Network
Non-Statin Therapies for Elevated LDL-C: The Role of Inclisiran (and Other Therapeutics)
FEATURING
Jacques Genest
- 864 views
- July 26, 2023
- 5
Cardiovascular Disease Management: A Case-Based Approach 2018
PCI Post ORBITA: Does This Really Change Our Treatment of Chronic Stable Angina?
FEATURING
Kirk Garratt
- 858 views
- December 21, 2018
- 2
Houston Methodist DeBakey Heart and Vascular Center
Power of Zero: Shaping Past, Present and Future of Cardiovascular Risk Assessment & Management
FEATURING
Khurram Nasir
- 849 views
- October 28, 2022
- 2
Cleveland Clinic European Society of Cardiology 2016 Symposium
The Science of HDL and Reverse Cholesterol Transport
- 848 views
- September 16, 2016
- 3
National Lipid Association
Bempedoic Acid: Mechanism of Action, Effects and Potential Uses
FEATURING
Anne Goldberg
- 841 views
- March 19, 2020
- 3
Baystate Health
Ozempic, Zepbound, and More: Behavioral Interventions & Weight Loss Medications For Heart Health
FEATURING
Michele Gortakowski,
Kathryn Jobbins
- 841 views
- May 22, 2024
- 11
ACC 2023 Conference Coverage
ACC 2023: Elevated Lp(a) - Actionable With Today's Evidence-Lipoprotein-Apheresis
FEATURING
Patrick Moriarty
- 840 views
- March 17, 2023
- 3
ASPC 2018 Congress on CVD Prevention
Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Higher CVD Risk
FEATURING
Patrick Moriarty
- 834 views
- August 10, 2018
- 10
Cardiovascular Disease Management - 5th Annual Symposium
Statins are Way Underused… and it’s Killing Americans
FEATURING
Dinesh Kalra
- 828 views
- December 27, 2017
- 6
Naveed Sattar
Can Empagliflozin Successfully Treat T2D Whilst Preventing Heart Failure and Protecting Renal Function?
- 819 views
- November 25, 2020
- 3
Cardiometabolic Health Congress (CMHC)
CMHC Highlights: Discussion on Lipids and Atherosclerosis Risk Assessments
- 815 views
- January 18, 2022
- 9
National Lipid Association
Primary Prevention: A Primer on Cholesterol Screening and Treatment of Hypercholesterolemia in Youth
FEATURING
Don P. Wilson
- 813 views
- October 11, 2023
- 11
Scripps Health
Lp(a) Lowering Therapies: Are Statins, PCSK9i, Lipoprotein Apheresis and RNAi Effective and Safe?
FEATURING
Calvin Yeang
- 805 views
- July 7, 2021
- 4
Naveed Sattar
What Do We Now Know About the Link Between Weight Gain, Diabetes and CV Risk?
- 804 views
- November 25, 2020
- 3
Novartis Cardiology
Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowering Therapy
- 798 views
- August 30, 2024
- 2
National Lipid Association
Update on Evinacumab: ANGPTL3 and Lipid Management
FEATURING
P. Barton Duell
- 795 views
- March 20, 2020
- 9
National Lipid Association
Update on Pharmacotherapy for Obesity
FEATURING
Harold Bays
- 789 views
- March 23, 2020
- 2